Merck launches health reference tome

Share this article:
Merck launches health reference tome
Merck launches health reference tome
Merck's nonprofit publishing arm launched a 2,500-page health reference book for consumers, available in hardcover or via iPhone app.

The book, titled The Merck Manual Home Health Handbook, was launched in response to survey data showing that 64% of consumers named physicians as their most trusted source of health information. The Merck reference book is authored by “300 key worldwide medical experts,” according to a statement. The book costs $28.76 at Amazon.com.

The iPhone app, developed in collaboration with app-developer Agile Partners and available through the iTunes store for $9.99, offers the same content as the hardback edition. Users of the app can share health topics via email and bookmark favorite subjects, the statement said.

“In addition to the latest health care and medical information, we included a practical ‘emergencies and injuries' section that is accessible from the app home screen,” said Robert Porter, editor-in-chief of The Merck Manuals, in the statement.

Merck concurrently launched a professional version of the app for doctors and nurses. That version costs $29.99, and features information on symptoms, text searches, and a bookmarking system that records a history of topics viewed by a physician.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...